HALPRYZA

EUIPO EUIPO 2015 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark HALPRYZA was filed as Word mark on 06/26/2015 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/11/2016. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 014298061
Application date June 26, 2015
Publication date September 28, 2015
Entry date January 11, 2016
Expiration date June 26, 2025

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases; pharmaceutical preparations, for the treatment, prevention and/or diagnosis of central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders; pharmaceutical preparations, for the treatment, prevention and/or diagnosis of kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders; pharmaceutical preparations for the treatment, prevention and/or diagnosis of Parkinson's disease, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants; pharmaceutical and veterinary preparations; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Trademark history

Date Document number Area Entry
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11014298061